Published in Gene Therapy Weekly, February 9th, 2006
In the January 2006 issue of Cancer Cell, a team led by Qunyan Yu, MD, and Piotr Sicinski, MD, PhD, of the Dana-Farber Cancer Institute, report that the interaction of a certain mutated oncogene and the newly described growth control flaw is seen in about 10% of breast cancers - and the deadliest ones (Requirement for CDK4 kinase function in breast cancer. Cancer Cell, January 2006;9(1):23-32).
The cancer results from a cascade of molecular events....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly